Gossamer Bio, Inc.
GOSS· Nasdaq
GOSSGossamer Bio, Inc.
Filed May 12, 2020 · 10-Q · 42 days after period end · 0001564590-20-024690
| Metric | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|
| Net Income | -$54.07M | -$32.61M | -$26.04M |
| EPS Diluted | -$0.87 | -$0.90 | -$4.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Gossamer Bio, Inc. · CIK 1728117 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 12, 2020 · 42 d after period end
